Antiviral effects of recombinant adenovirus AdMxA in vitro on HBV

MAO Guoqiang,PENG Mingli,ZHAO Ruiqiu,HUANG Qin,LIU Aiping,REN Hong,XU Hongmei
DOI: https://doi.org/10.3969/j.issn.1671-6825.2011.02.031
2011-01-01
Abstract:Aim:To investigate the anti-HBV effects with the recombinant adenovirus AdMxA in vitro.Methods:The levels of MxA mRNA were detected by RT-PCR and the tites of HBsAg and HBeAg were detected by ELASE after HepG2.2.15 cells were transfected by 1 MOI or 5 MOI of recombinant adenovirus AdMxA.And the control group was HepG2.2.15 cells without transfection.Results:The levels of MxA mRNA in HepG2.2.15 cells transfected with recombinant adenovirus AdMxA were increased significantly compared with the control group(F=226.294,P<0.001).The titers of HBsAg and HBeAg in HepG2.2.15 cells transfected with recombinant adenovirus AdMxA were lower significantly than those in HepG2.2.15 cells without recombinant adenovirus AdMxA(F were 94.519 and 44.065 respectively,P<0.001 in both).There was no difference between 1 MOI and 5 MOI groups in the titers of of HBsAg and HBeAg(P>0.05).Conclusion:It indicates that the replication and expression of HBV in HepG2.2.15 cells can be inhibited after the recombinant adenovirus AdMxA transfected.It may be an effective way of gene therapy of HBV infection with recombinant adenovirus AdMxA.
What problem does this paper attempt to address?